Kartini Asari

Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation

B. Ng, C. Chuah, D. White, 2021, Anti-cancer drugs.

In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy

S. Heatley, D. White, T. Hughes, 2021, Leukemia & lymphoma.

Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration

C. Chuah, D. Virshup, H. Than, 2015, Oncotarget.

Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia.

B. Ng, P. Casey, C. Chuah, 2016, Experimental hematology.